Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mazdutide in Alcohol Use Disorder
NCT06817356Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2025
- Primary completion
- Mar 2026
- Modality
- Hormonal Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of mazdutide in alcohol use disorder (AUD), sponsored by Eli Lilly and Company. Started Feb 2025; status: completed.
02
Drugs
mazdutide
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06817356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06817356.